Predictive value of estrogen receptor status as assessed by ligand-binding assay in patients with early-stage breast cancer treated with breast conserving surgery and radiation therapy

Oncology Reports

Volumn 9, Issue 2, 2002, Pages 375-378

  Takei, Hiroyuki ^a,b   Horiguchi, Jun ^a   Maemura, Michio ^a   Koibuchi, Yukio ^a   Oyama, Tetsunari ^a   Yokoe, Takao ^a   Iino, Yuichi ^a   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

Author keywords

Breast conserving surgery; Estrogen receptor; Predictive factor; Progesterone receptor; Radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; LIGAND; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; BREAST TUMOR; CANCER STAGING; DISEASE FREE SURVIVAL; ENZYME IMMUNOASSAY; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; RADIOTHERAPY; SEGMENTAL MASTECTOMY;

ADENOCARCINOMA; ADENOCARCINOMA, SCIRRHOUS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LIGANDS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOTHERAPY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 0036518588     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.2.375     Document Type: Article

References (12)

1. Fisher B and Redmond C: Lumpectomy for breast cancer: an update of the NSABP experience. J Natl Cancer Inst Monogr 11: 7-13, 1992.
2. van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van Zijl K and Bartelink H: Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92: 1143-1150, 2000.
3. Kurtz JM, Amalric R, Brandone H, Ayme Y, Jacquemier J, Pietra JC, Hans D, Pollet JF, Bressac C and Spitalier JM: Local recurrence after breast-conserving surgery and radiotherapy: frequency, time course, and prognosis. Cancer 63: 1912-1917, 1989. (Pubitemid 19118888)
4. Fourquet A, Campana F, Zafrani B, Mosseri V, Vielh P, Durand JC and Vilcoq JR: Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 17: 719-725, 1989. (Pubitemid 19250523)
5. Horiguchi J, Iino Y, Takei H, Sugamata N, Maemura M, Yokoe T, Morishita Y, Niibe H, Mitsuhashi N, Yamakawa M, Nakajima T, Oyama T, Shiozaki H, Ishida T, Endo K, Takano A, Fujii T and Yokomori T: Comparison of breast-conserving therapy with mastectomy for treatment of early breast cancer. Anticancer Res 17: 3849-3856, 1997.
6. Voogd AC, Nielsen M, Peterse JL, Blichert-Toft M, Bartelink H, Overgaard M, van Tiernhoven G, Andersen KW, Sylvester RJ, van Dongen JA for the Danish Breast Cancer Cooperative Group and the Breast Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer: Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 19: 1688-1697, 2001. (Pubitemid 32230869)
7. Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, Siver B, Hetelekidis S, Abner A, Harris JR and Schnitt SJ: Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18: 1668-1675, 2000. (Pubitemid 30220545)
8. Yaghan R, Stanton PD, Robertson KW, Going JJ, Murray GD and McArdle CS: Oestrogen receptor status predicts local recurrence following breast conservation surgery for early breast cancer. Eur J Surg Oncol 24: 424-426, 1998. (Pubitemid 28479094)
9. Clark GM, Osborne CK and McGuire WL: Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J Clin Oncol 2: 1102-1109, 1984. (Pubitemid 14022697)
10. Pink JJ and Jordan VC: Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res 56: 2321-2330, 1996. (Pubitemid 26154081)
11. Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351: 1451-1467, 1998.
12. Buchholz TA, Tucker SL, Erwin J, Mathur D, Strom EA, McNeese MD, Hortobagyi GN, Cristofanilli M. Esteva FJ, Newman L, Singletary SE, Buzdar AU and Hunt KK: Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J Clin Oncol 19: 2240-2246, 2001. (Pubitemid 32372325)